ADIPOQ and dry eye syndrome: As a further support for the presence of AdipoR1/R2 in corneal epithelial cells, topically administered adiponectin proved effective to reduce inflammation of the ocular surface in a mouse model of experimental dry eye [98] and corneal neovascularization in a rabbit [99].